JP2021525730A5 - - Google Patents

Info

Publication number
JP2021525730A5
JP2021525730A5 JP2020566662A JP2020566662A JP2021525730A5 JP 2021525730 A5 JP2021525730 A5 JP 2021525730A5 JP 2020566662 A JP2020566662 A JP 2020566662A JP 2020566662 A JP2020566662 A JP 2020566662A JP 2021525730 A5 JP2021525730 A5 JP 2021525730A5
Authority
JP
Japan
Prior art keywords
alkyl
heteroaryl
aryl
pharmaceutically acceptable
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020566662A
Other languages
English (en)
Japanese (ja)
Other versions
JP7465819B2 (ja
JP2021525730A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/000691 external-priority patent/WO2019229536A2/en
Publication of JP2021525730A publication Critical patent/JP2021525730A/ja
Publication of JP2021525730A5 publication Critical patent/JP2021525730A5/ja
Application granted granted Critical
Publication of JP7465819B2 publication Critical patent/JP7465819B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020566662A 2018-05-29 2019-05-29 新規ベンゾジアゼピン誘導体及びそれらの使用 Active JP7465819B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862677498P 2018-05-29 2018-05-29
US62/677,498 2018-05-29
PCT/IB2019/000691 WO2019229536A2 (en) 2018-05-29 2019-05-29 Novel benzodiazepine derivatives and uses thereof

Publications (3)

Publication Number Publication Date
JP2021525730A JP2021525730A (ja) 2021-09-27
JP2021525730A5 true JP2021525730A5 (cg-RX-API-DMAC7.html) 2022-06-07
JP7465819B2 JP7465819B2 (ja) 2024-04-11

Family

ID=68692822

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020566662A Active JP7465819B2 (ja) 2018-05-29 2019-05-29 新規ベンゾジアゼピン誘導体及びそれらの使用

Country Status (12)

Country Link
US (2) US11084801B2 (cg-RX-API-DMAC7.html)
EP (1) EP3802546A4 (cg-RX-API-DMAC7.html)
JP (1) JP7465819B2 (cg-RX-API-DMAC7.html)
KR (1) KR102946423B1 (cg-RX-API-DMAC7.html)
CN (2) CN112166115A (cg-RX-API-DMAC7.html)
AU (2) AU2019276833A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020023623A2 (cg-RX-API-DMAC7.html)
CA (1) CA3100141A1 (cg-RX-API-DMAC7.html)
EA (1) EA202092909A1 (cg-RX-API-DMAC7.html)
IL (1) IL278973B2 (cg-RX-API-DMAC7.html)
MX (1) MX2020012718A (cg-RX-API-DMAC7.html)
WO (1) WO2019229536A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102710962B1 (ko) 2017-07-04 2024-09-27 주식회사 인투셀 절단성 링커를 포함하는 화합물 및 이들의 용도
CN112166115A (zh) 2018-05-29 2021-01-01 尹图赛利有限公司 新型苯二氮杂*衍生物及其用途
EP3873912B1 (en) 2018-10-31 2026-03-25 Intocell, Inc. Fused heterocyclic benzodiazepine derivatives and uses thereof
MX2021008095A (es) * 2019-01-03 2021-08-05 Intocell Inc Compuestos que comprenden un enlazador escindible y sus usos.
EP3906063A4 (en) 2019-01-03 2023-03-01 Intocell, Inc. COMPOUNDS COMPRISING A CLEAVABLE LINKER AND THEIR USES
CN114728075B (zh) * 2019-12-02 2025-10-03 尹图赛利有限公司 与分子缀合相关的组合物和方法
CN115942978A (zh) * 2020-06-26 2023-04-07 尹图赛利有限公司 包含抗b7-h3抗体的抗体-药物缀合物
AU2022282449A1 (en) * 2021-05-27 2023-11-30 Fusion Pharmaceuticals Inc. 2,6-dichlorophenyl ester compounds and use thereof
CN119350387A (zh) * 2022-03-03 2025-01-24 西北工业大学 新型可光催化剪切的羧酸保护基磷酰氧基-4-香豆素基甲基类化合物及其氨基酸衍生物的制备方法
CN119424671A (zh) 2023-08-01 2025-02-14 上海新理念生物医药科技有限公司 含糖基吡啶型连接子的抗体药物偶联物
WO2025262641A1 (en) * 2024-06-19 2025-12-26 Pheon Therapeutics Ltd Antibody drug conjugates that bind cdcp1 and uses thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843937A (en) 1996-05-23 1998-12-01 Panorama Research, Inc. DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
GB0819095D0 (en) * 2008-10-17 2008-11-26 Spirogen Ltd Pyrrolobenzodiazepines
CA3014224C (en) 2009-02-05 2022-05-24 Immunogen, Inc. Condensed benzodiazepine-indoline derivatives and processes to prepare said derivatives
AU2012322934B2 (en) * 2011-10-14 2016-09-08 Medimmune Limited Pyrrolobenzodiazepines
CA2850375C (en) 2011-10-14 2019-07-02 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
HK1211208A1 (zh) 2012-08-22 2016-05-20 Immunogen, Inc. 細胞毒性苯並二氮呯衍生物
US10131682B2 (en) 2012-11-24 2018-11-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
KR102384740B1 (ko) * 2013-12-27 2022-04-07 자임워크스 인코포레이티드 약물 접합체를 위한 설폰아마이드-함유 연결 시스템
US10973920B2 (en) 2014-06-30 2021-04-13 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
TW201632531A (zh) * 2015-01-14 2016-09-16 必治妥美雅史谷比公司 苯二氮呯二聚物,其結合物及製造與使用方法
CN107231804B (zh) 2015-01-14 2019-11-26 百时美施贵宝公司 亚杂芳基桥连苯并二氮杂*二聚体、其缀合物及制备和使用方法
KR20170128256A (ko) 2015-03-18 2017-11-22 시애틀 지네틱스, 인크. Cd48 항체 및 이의 접합체
US9504694B2 (en) 2015-03-19 2016-11-29 Cellerant Therapeutics, Inc. Isoquinolidinobenzodiazepines
EP3458050A1 (en) 2016-05-20 2019-03-27 Abbvie Stemcentrx LLC Anti-dll3 drug conjugates for treating tumors at risk of neuroendocrine transition
WO2018053552A2 (en) * 2016-09-19 2018-03-22 Cellerant Therapeutics, Inc. Isoquinolidinobenzodiazepines
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
JP7527787B2 (ja) * 2017-03-24 2024-08-05 シージェン インコーポレイテッド グルクロニド薬物-リンカーの調製のためのプロセスおよびその中間体
WO2018195243A1 (en) 2017-04-20 2018-10-25 Immunogen, Inc. Cytotoxic benzodiazepine derivatives and conjugates thereof
KR102710962B1 (ko) 2017-07-04 2024-09-27 주식회사 인투셀 절단성 링커를 포함하는 화합물 및 이들의 용도
GB201714115D0 (en) * 2017-09-04 2017-10-18 Femtogenix Ltd Cytotoxic agents
CN112166115A (zh) 2018-05-29 2021-01-01 尹图赛利有限公司 新型苯二氮杂*衍生物及其用途
EP3873912B1 (en) 2018-10-31 2026-03-25 Intocell, Inc. Fused heterocyclic benzodiazepine derivatives and uses thereof
KR102503143B1 (ko) 2019-03-06 2023-02-24 주식회사 레고켐 바이오사이언스 인간 dlk1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도
CN115942978A (zh) 2020-06-26 2023-04-07 尹图赛利有限公司 包含抗b7-h3抗体的抗体-药物缀合物

Similar Documents

Publication Publication Date Title
JP2022510505A5 (cg-RX-API-DMAC7.html)
JP7229202B2 (ja) 標的化薬物結合体と使用するためのメチレンカルバメートリンカー
CN114053426B (zh) 一种双药链接组装单元及双药靶向接头-药物偶联物
JP2025510629A (ja) カンプトテシンコンジュゲート
FI105155B (fi) Menetelmä terapeuttisesti käyttökelpoisten sappihappojohdannaisten valmistamiseksi
JP2022082777A (ja) Peg化薬物リンカー及びその中間体を調製するためのプロセス
JP2022527114A5 (cg-RX-API-DMAC7.html)
JP2023105175A (ja) グルクロニド薬物-リンカーの調製のためのプロセスおよびその中間体
KR20220052918A (ko) 치료제로서의 사이토톡신의 펩티드 접합체
MXPA05010471A (es) Profarmacos inhibidores de quinasa pi-3.
JP6929292B2 (ja) 新規なクリプトフィシン化合物およびコンジュゲート、これらの製造およびこれらの治療用途
IL315310A (en) Irak degraders and uses thereof
US20090246211A1 (en) Molecular constructs suitable for targeted conjugates
JP2006523237A5 (cg-RX-API-DMAC7.html)
KR20180030993A (ko) 항체-약물 접합체 중의 공유결합 링커 및 이의 제조방법 및 사용방법
CN101909441A (zh) 微管蛋白抑制剂及其制备方法
JP2012516896A5 (cg-RX-API-DMAC7.html)
KR20160045146A (ko) 마크롤라이드 디아스테레오머를 포함하는 약제학적 조성물, 이의 합성 방법 및 치료학적 용도
CN105899515A (zh) uncialamycin的衍生物、合成方法及其作为抗肿瘤剂的用途
JP2022515884A5 (cg-RX-API-DMAC7.html)
JP2018512424A (ja) エステル化のための試薬及び方法
Makarov et al. Modification of 3, 5-bis (arylidene)-4-piperidone pharmacophore by phosphonate group using 1, 2, 3-triazole cycle as a linker for the synthesis of new cytostatics
CN114874204A (zh) 靶向SARS-CoV-2 3C蛋白酶的PROTAC分子及其应用
US11117907B2 (en) Curcuminoid-inspired synthetic compounds as anti-tumor agents
TWI825169B (zh) 妥布賴森(tubulysins)及其中間體之製備之替代方法